Médecine personnalisée versus médecine de la personne : une fausse alternative

Authors

  • Xavier Guchet Université de Technologie de Compiègne

DOI:

https://doi.org/10.20416/lsrsps.v4i2.813

Keywords:

Biomarqueur, bio-objet, personne

Abstract

Personalized medicine has recently become the new horizon of healthcare policies worldwide, but it has
also given rise to misunderstandings and conflicting debates due to the lack of clear definitions and appropriate framing. Personalized medicine is mainly defined as the tailoring of diagnosis and therapies to the genetic profile of each patient, both enhanced by considerable improvements of technologies for acquiring and processing large amounts of data. Is personalized medicine the right term however, considering that it focuses on signaling pathways at the molecular level, where undoubtely persons as such cannot be found?
The rival expression «person-centered medicine» has been coined to avoid any ambiguity: on the one hand, molecular biomedicine improved by high-throughtput molecular technologies is more legitimately labelled «individualized» or «precision» medicine, while on the other hand «person-centered medicine» is considered the only authentic personalized medicine insofar as it focuses on the patient as a whole.
Far from overcoming the misunderstandings and conflicting views at stake in current debates on future
medicine however, this divide between personalized and person-centered medicine gives rise to new difficulties and proves to be misleading. Conceptual confusions remain underinvestigated and undermine current attempts to clarify core issues of biomedical research and biomedicine today. This paper intends to
highlight these confusions.

Author Biography

Xavier Guchet, Université de Technologie de Compiègne

Professeur des Universités, philosophie, rattaché à l'EA COSTECH (EA 2223)

 

References

Boniolo G., De Anna G., Vincenti U. Individuo e persona. Tre saggi su chi siamo, Milano, RCS Libri S.p.A., 2007

Buck Louis G. M., Sundaram R. (2012).Exposome: Time for Transformative Research, Stat Med., 31(22)

Cambrosio A., Keating P. Cancer on Trial: Oncology as a New Style of Practice, Chicago: University of Chicago Press, 2012

Canguilhem G., Le Normal et le pathologique, Paris, PUF, 1966 [1943]

Canguilhem G., « Le vivant et son milieu », in La Connaissance de la vie, Paris, Vrin, 1980

Deleuze G., « Post-scriptum sur les sociétés de contrôle », in Pourparlers. 1972-1990, Paris, Les Editions de Minuit, 1990/2003, p.240-247

Espín-Pérez A. et al (2014). "OMICS-based" biomarkers for Environmental Health Studies, Curr Envir Health Rpt, 1:353-362

Fagot-Largeault A., « Les droits de l’embryon (fœtus) humain et la notion de personne humaine potentielle », in Médecine et philosophie, Paris, PUF, 2010, p.103-143

Guchet X., La Médecine personnalisée. Un essai philosophique, Paris, Les Belles Lettres, Coll. Médecine & Sciences Humaines, 2016

Hacking I. (2006). Making Up People, London Review of Books, 28(16):23-26

Holmberg T. et al (2011). Bio-objects and the Bio-objectification Process, Croat Med J, 52(6):740-742

Housset E., La Vocation de la personne. L’Histoire du concept de personne de sa naissance augustinienne à sa redécouverte phénoménologique, Paris, PUF, coll. Epiméthée, 2007

Jaspers K., Philosophie. Orientation dans le monde. Eclairement de l’existence. Métaphysique, Paris, Berlin, Heidelberg, Springer-Verlag, 1989

Jones D. P. (2016). Sequencing the Exposome: a Call to Action, Toxicology Reports, 3:29-45

Kalow, W. Phamacogenetics, Heredity and the Response to Drugs, W. B. Saunders Co., West Washington Square, Philadelphia 5, 1962

Keller M. P. et al (2015). The Integration of Social, Behavioral and Biological Mechanisms in Models of Pathogenesis, Perspectives in Biology and Medicine, 57(3):308-328

Langreth, R., Waldholz, M. (1999). “New Era of Personalized Medicine. Targeting Drugs for Each Unique Genetic Profile”, The Oncologist, vol.4, n°5:426-427

Levin N. (2014). Making up “persons” in personalized medicine with metabolomics (http://somatosphere.net/2014/02/making-up-persons-in-personalized-medicine-with-metabolomics.html)

Lewontin R., La Triple hélice. Les gènes, l’organisme, l’environnement, Paris, Éditions du Seuil, 2003 [2001]

Lock M., Nguyen V. K. (2010). An Anthropology of Biomedicine, John Wiley & Sons

Masquelet A.-C., « Le soin à l’épreuve de la cure », in Doron C.-O., Lefève C., Masquelet A.-C. (dir.), Soin et subjectivité, Paris, PUF, 2011

Metzler I., Webster A. (2011). Bio-objects and their Boundaries: Governing Matter at the Intersection of Society, Politics and Science, Croat Med J, 52(5):648-650

Miller, G.W., Jones, D.P. (2014). The Nature of Nurture: Refining the Definition of the Exposome. Toxicol. Sci., 137(1):1-2

Mounier E., Le Personnalisme, Paris, PUF, 1949

Motulsky, A. (1957). Drug Reactions, Enzymes and Biochemical Genetics. JAMA 165, 835-837

Nelson N. C., Keating P., Cambrosio A. (2013). On Being "Actionable": Clinical Sequencing and the Emerging Contours of a Regime of Genomic Medicine in Oncology, New Genetics and Society, Vol.32, Issue 4:405-428

Özdemir V. et al (2015). Personalized Medicine beyond genomics: Alternative Futures in Big Data – Proteomics, Environtome and Social Proteome, J Neural Transm

Peters, A., et al (2012). Understanding the link between environmental exposures and health: does the exposome promise to much? J. Epidemiol. Community Health, 66:103-105

Rappaport S. M. et al (2010). Environment and Disease Risks, Science, 330:460-61

Rappaport S. M. (2011). Implications of the Exposome for Exposure Sciences, Journal of Exposure Science and Environmental Epidemiology, 21:5-9

Rappaport S. M. et al (2014). The Blood Exposome and its Role in Discovering Causes of Disease, Environmental Health Perspectives, 122(8) :

Russo F., Williamson J. (2012). EnviroGenomarkers: the Interplay between Mechanisms and Difference Making in Establishing Causal Claims, Medicine Studies, 3(4):249-262

Sève L., Pour une critique de la raison bioéthique, Paris, Odile Jacob, 1994

Sève L., Qu’est-ce que la personne humaine ? Bioéthique et démocratie, Paris, La Dispute/Snédit, 2006

Virgin H. W., Todd J. A. (2011). Metagenomics and Personalized Medicine, Cell, 147, Sept. 30

Vineis P. et al (2009). The Impact of New Research Technologies on our Understanding of Environmental Causes of Disease: the Concept of Clinical Vulnerability, Environmental Health, 8(54):

Vineis, P. et al (2016). The Exposome in Practice: Design of the EXPOsOMICS Project. Int. J. Hyg. Environ., online

Wild C. P. (2005). Complementing the Genome with an "Exposome": the Oustanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology, Cancer Epidemiology, Biomarkers & Prevention, 14:1847-1850

Wild C. P. (2012). The Exposome: from Concept to Utility, International Journal of Epidemiology, 41: 24-32

Wheeler B. (2015). Searching for Productive Causes in Big Data: the Information-Transmission Account, http://philsci-archive.pitt.edu/11717/

Downloads

Published

2018-03-27

How to Cite

Guchet, Xavier. 2018. “Médecine personnalisée Versus médecine De La Personne : Une Fausse Alternative”. Lato Sensu: Revue De La Société De Philosophie Des Sciences 4 (2). https://doi.org/10.20416/lsrsps.v4i2.813.

Issue

Vol. 4 No. 2 (2017): Numéro spécial sur la médecine personnalisée

Section

Contemporary issues in personalized medicine

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.